KYIV. Oct 18 (Interfax-Ukraine) – The United States Department of Agriculture (USDA) has downgraded its forecast for maize exports from Ukraine in the 2017/2018 marketing year (MY, July-June) by 500,000 tonnes compared to the forecast in September, to 21.5 million tonnes.
According to a report on the website of the U.S. department, the forecast for corn yield in 2017 is also reduced by 500,000 tonnes, to 27 million tonnes, compared to the September forecast.
In general, the USDA predicts grain harvest in Ukraine in 2017 at the level of 63.49 million tonnes, including 26.5 million tonnes of wheat.
According to the forecasts of the U.S. agency, grain exports in the 2017/2018 MY will amount to 42.81 million tonnes, of which wheat is 16.5 million tonnes.
As reported, with reference to the preliminary data from the Ministry of Agrarian Policy and Food, grain and flour exports in the 2016/2017 MY totaled 44.44 million tonnes.
KYIV. Oct 18 (Interfax-Ukraine) – The State Property Fund of Ukraine (SPF) plans in 2018 to sell Odesa Port-Side Chemical Plant, Centrenergo, Turboatom, six regional power supply companies, the Agrarian Fund, the State Food and Grain Corporation of Ukraine, acting SPF head Vitaliy Trubarov has stated.
“The fund expects the transfer of the Agrarian Fund and the State Food and Grain Corporation of Ukraine. As for Turboatom, we are now working with the Cabinet to determine the size of the stake which will be put up for sale,” he said at a meeting of the American Chamber of Commerce.
Trubarov informed that an inventory has already been completed at Odesa Port-Side Chemical Plant, while the starting price of the enterprise will be determined in November.
“In November we will get the starting price, and in December this year, if all participants in the process meet the deadlines, we’ll manage to start accepting applications from potential investors so that we could start the sale itself in spring 2018,” the SPF head said.
KYIV. Oct 18 (Interfax-Ukraine) – Transnational Indian pharmaceutical companies operating in Ukraine remain committed to the drug affordability strategy, according to Dr. Ramanan Menon, the head of the Indian Pharmaceutical Manufacturers’ Association (IPMA).
“Most transnational Indian companies are currently present on the Ukrainian market. These companies supply good-quality goods at an affordable price. These medicines have always been in demand among Ukrainian patients,” he told Interfax-Ukraine, while commenting on the presence of Indian pharmaceutical companies on the Ukrainian market.
According to Dr. Menon, Indian pharmaceutical companies supply mainly generics and branded generics to Ukraine. At the same time, many Indian pharmaceutical companies are working towards the development of innovative drugs, having their own research centers.
While commenting on the participation of Indian pharmaceutical companies in the procurement of medicines for state budget funds, the IPMA chief noted that the results of budget purchases, in particular, on HIV/AIDS and tuberculosis treatment programs, had confirmed the effectiveness of procurement of drugs manufactured by Indian pharmaceutical companies.
“Last year’s results show that Indian companies have a significant share. They all have WHO prequalification and are quite affordable,” he said.
According to him, in particular, there is a high share of Indian pharmaceutical companies in the segment of anti-tuberculosis and antiretroviral drugs, in the production of which India has always been among the world leaders.
So, according to the Business Credit company, in 2016, Ukrainian clinics used Indian drugs to treat HIV/AIDS for an amount exceeding $326,000 (50,600 packs), and over $10.855 million (1.904 million packs) was spent on drugs to treat tuberculosis. According to some positions, the share of Indian drugs in this category reaches almost 57% of purchased drugs.
The IPMA head noted that currently more than 80% of antiretroviral drugs used globally to fight AIDS are produced by Indian pharmaceutical companies. In particular, the Medicines Patent Pool, an UN-funded patent organization, signed six sub-licenses with Indian pharmaceutical companies Aurobindo, Cipla, Desano, Emcure, Hetero Labs and Laurus Labs, which allowed them to create a new drug to treat AIDS – generic Tenofovir Alafenamide (TAF) for 112 developing countries.
“I can state that the share of Indian pharmaceutical manufacturers in budget purchases has not decreased. International organizations that purchase medicines under these programs for state budget funds have the opportunity to purchase them directly at the central offices of pharmaceutical companies, so trading are also manufacturers who were previously not present on the Ukrainian market,” he said.
The IPMA head noted that Indian pharmaceutical companies were implementing a strategy to increase the affordability of medicines.
“A high-quality and effective drug is not always the most expensive. Of course, generics are cheaper than original drugs. The expansion of the presence of high-quality generics is one of the tools to increase the affordability of drugs. Therefore, Indian companies have a demand in various markets of the world. The consumer is not the same in terms of capabilities and needs, and therefore generics have a demand even in developed markets, where the income of the population is high, and in countries with strict regulatory policies, where quality is paramount,” he said.
KYIV. Oct 18 (Interfax-Ukraine) – The major pipe enterprises of Ukraine in January-September 2017 increased production of pipes by 25.9% compared to the same period last year, to 783,800 tonnes, including in September they manufactured 92,100 tonnes.
The Ukrtruboprom association told Interfax-Ukraine its enterprises in January-September 2017 increased pipe production by 30.4%, to 520,000 tonnes, in September making 60,800 tonnes.
Khartsyzsk Pipe Plant (Donetsk region), located in the ATO zone, in January-September 2017 made 3,400 tonnes of pipes (it was idle in September), whereas in January-September of 2016 it made 11,500 tonnes.
Pipe production at Interpipe Nyzhniodniprovsky Pipe Rolling Plant in the period rose by 68.4% compared to January-September 2016, to 190,800 tonnes (21,800 tonnes in September), Interpipe Novomoskovsk Pipe Plant decreased output by 12.5%, to 72,100 tonnes (7,800 tonnes in September), while Interpipe Niko Tube raised production by 39.9%, to 218,800 tonnes (26,600 tonnes in September).
Dnipropetrovsk Pipe decreased pipe production by 15.7%, to 15,000 tonnes, making 1,300 tonnes in September. Production at Centravis grew by 6.2%, being 13,700 tonnes of stainless pipes (1,600 tonnes in September).
Trubostal saw a 9.5% rise in pipe production, to 2,300 tonnes (300 tonnes in September) and Nikopol Steel Pipe Plant YUTIST saw a 62.5% rise, to 3,900 tonnes (400 tonnes in September).
Mariupol Illich steel works, which is not a member of the association, saw a 76.2% rise in pipe production in January-September 2017, to 116,500 tonnes (14,900 tonnes in September) and production at Kominmet grew by 6.6%, to 147,300 tonnes (16,400 tonnes).
Luhansk Pipe Rolling Plant, created on the basis of Luhansk Pipe Plant, remained idle in January-September 2017. AG Stal LLC was also idle in January-September 2017.
KYIV. Oct 17 (Interfax-Ukraine) – Investment of Delta Wilmar CIS and Grain Agro Invest in projects on construction of oilseeds refineries, a grain terminal and transshipment facilities in Odesa region could reach $300 million.
“Investors from Singapore and the United States will build two new oilseed refineries, a grain terminal and transshipment facilities in Lymansky district of Odesa region. Total investment in the projects will be around $300 million. Over 500 new jobs will be created,” Advisor to the head of Odesa Regional Administration Kostiantyn Chyzhyk told Interfax-Ukraine.
He said that the trilateral memorandum was signed on October 10 by Head of Odesa Regional Administration Maskym Stepanov, Director of Delta Wilmar CIS Andriy Romanov and Director of Grain Agro Invest Serhiy Tormos.
According to the arrangements between the regional administration and foreign investors, two investment projects worth $150 million each will be started.
Delta Wilmar CIS will expand its production facilities and will build a new oilseed refinery with a total annual capacity of over 600,000 tonnes and a berth to transship oil and cake with an annual capacity of up to 3 million tonnes.
The company will create around 200 new jobs and will pay some UAH 500 million to the budget every year.
The company with U.S. investment Grain Agro Invest will build a grain storage and transshipment complex and an oilseed refinery. The annual capacity of the new berth will be up to 3 million tonnes. Some 300 new jobs will be created.
Delta Wilmar CIS LLC was created in 2004. It specialized in production of oil and fat products and ingredients for bakery, confectionery and dairy products at a factory in Yuzhne (Odesa region).
KYIV. Oct 17 (Interfax-Ukraine) – Sugar production in Ukraine as of October 11, 2017 totaled 502,100 tonnes.
The Ukrtsukor national association of sugar producers reported that as of October 11, 2017, a total of 39 sugar refineries were operating. They refined 3.72 million tonnes of sugar beets.
As reported, Ukraine started sugar refining season on August 30, 2017.
Ukrtsukor said that in 2017/18 agricultural year (September-August) some 46 sugar refineries will operate.
According to the association’s forecasts, sugar production this agri-year will be around 1.9 million tonnes. Exports could reach 500,000 tonnes.
Sugar beets were sowed on 318,000 ha in 2017.
